Fingerprint
Dive into the research topics of 'Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically